- $37.77bn
- $45.25bn
- $32.72bn
- 93
- 66
- 88
- 95
R2018 December 31st | C2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 27,449 | 28,132 | 27,587 | 29,206 | 32,723 |
Cost of Revenue | |||||
Gross Profit | 9,101 | 9,279 | 9,416 | 9,856 | 10,879 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 25,003 | 25,339 | 25,324 | 25,875 | 28,829 |
Operating Profit | 2,446 | 2,793 | 2,263 | 3,331 | 3,894 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,968 | 2,181 | 1,664 | 3,103 | 3,469 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,501 | 1,647 | 1,165 | 2,442 | 2,684 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 2,883 | 1,716 | 1,122 | 2,565 | 3,847 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 2,883 | 1,716 | 1,122 | 2,565 | 3,847 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.98 | 2.21 | 2.01 | 2.93 | 3.57 |
Dividends per Share |